Biotech · Private company
Teikoku Pharma USA, Inc.
Track this companyFree. Adds Teikoku Pharma USA, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 12 cm2 - 2 Active DMTS PatchesPhase 2 · AgitationClinicalTrials.gov · fetched Nov 12, 2026
- 350 mg Donepezil Transdermal PatchPhase 2 · Irritation/IrritantClinicalTrials.gov · fetched Nov 12, 2026
- DMTSPhase 2 · Pain, PostoperativeClinicalTrials.gov · fetched Nov 12, 2026
- DMTS PatchPhase 2 · Pain, PostoperativeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypePHASE2 · ACTIVE_NOT_RECRUITING · started Sep 16, 2025ClinicalTrials.gov NCT06052254 · fetched Nov 12, 2026
- Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following AbdominoplastyPHASE2 · TERMINATED · started Jul 7, 2022ClinicalTrials.gov NCT05412992 · fetched Nov 12, 2026
- Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following AbdominoplastyPHASE2 · UNKNOWN · started Jul 7, 2020ClinicalTrials.gov NCT04242407 · fetched Nov 12, 2026
- Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-SystemPHASE2 · COMPLETED · started May 1, 2009ClinicalTrials.gov NCT00916383 · fetched Nov 12, 2026